Pierre Geborek

affiliated with the university
More filtering options
  1. Article
  2. Treatment with belimumab in SLE does not alter antobody response to 13-valent pneumococcal vaccine

    Johanna Nagel, Tore Saxne, Pierre Geborek, Anders Bengtsson, S Jacobsen, Svaerke Joergensen C, Jan-Åke Nilsson, Lillemor Skattum, Andreas Jönsen & Meliha C Kapetanovic, 2017, In : Lupus. 26, 10, p. 1072-1081

    Research output: Contribution to journalArticle

  3. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden

    JOHAN KARLSSON WALLMAN, Jonas K. Eriksson, Jan Åke Nilsson, Tor Olofsson, Lars Erik Kristensen, Martin Neovius & Pierre Geborek, 2016 Jul 1, In : Journal of Rheumatology. 43, 7, p. 1292-1299 8 p.

    Research output: Contribution to journalArticle

  4. Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.

    Lars Erik Kristensen, Elisabeth Lie, Lennart Jacobsson, Robin Christensen, Philip J Mease, Henning Bliddal & Pierre Geborek, 2016, In : Journal of Rheumatology. 43, 1, p. 81-87

    Research output: Contribution to journalArticle

  5. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

    Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan Karlsson, Ingemar Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven & Karin Lundberg, 2016, In : Annals of the Rheumatic Diseases. 75, 2, p. 356-361

    Research output: Contribution to journalArticle

  6. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

    Karen Hambardzumyan, Rebecca Bolce, Saedis Saevarsdottir, Scott E Cruickshank, Eric H Sasso, David Chernoff, Kristina Forslind, Ingemar Petersson, Pierre Geborek & Ronald F van Vollenhoven, 2015, In : Annals of the Rheumatic Diseases. 74, 6, p. 1102-1109

    Research output: Contribution to journalArticle

  7. Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.

    Ronald F van Vollenhoven, Rebecca Bolce, Karen Hambardzumyan, Saedis Saevarsdottir, Kristina Forslind, Ingemar Petersson, Eric H Sasso, C C Hwang, Oscar G Segurado & Pierre Geborek, 2015, In : Arthritis & Rheumatology. 67, 11, p. 2855-2860

    Research output: Contribution to journalArticle

  8. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial

    Saedis Saevarsdottir, Hamed Rezaei, Pierre Geborek, Ingemar Petersson, Sofia Ernestam, Kristina Albertsson, Kristina Forslind & Ronald F. van Vollenhoven, 2015, In : Annals of the Rheumatic Diseases. 74, 8, p. 1509-1514

    Research output: Contribution to journalArticle

  9. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

    Meliha C Kapetanovic, Lars Erik Kristensen, Tore Saxne, Teodora Aktas, Andreas Mörner & Pierre Geborek, 2014, In : Arthritis Research and Therapy. 16, 1, R2.

    Research output: Contribution to journalArticle

  10. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.

    Tor O Olofsson, Ingemar Petersson, Jonas Eriksson, Martin Englund, Julia F Simard, Jan-Åke Nilsson, Pierre Geborek, Lennart Jacobsson, Johan Askling & Martin Neovius, 2014, In : Annals of the Rheumatic Diseases. 73, 5, p. 845-853

    Research output: Contribution to journalArticle

  11. The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice

    Ingrid Lekander, Fredrik Borgstrom, Jorgen Lysholm, Ronald F. van Vollenhoven, Staffan Lindblad, Pierre Geborek & Gisela Kobelt, 2013, In : European Journal of Health Economics. 14, 6, p. 863-873

    Research output: Contribution to journalArticle

  12. Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial

    Jonas K. Eriksson, Martin Neovius, Johan Bratt, Ingemar Petersson, Ronald F. van Vollenhoven, Pierre Geborek & Sofia Ernestam, 2013, In : JAMA Internal Medicine. 173, 15, p. 1407-1414

    Research output: Contribution to journalArticle

  13. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

    Ronald F. van Vollenhoven, Pierre Geborek, Kristina Forslind, Kristina Albertsson, Sofia Ernestam, Ingemar Petersson, Katerina Chatzidionysiou & Johan Bratt, 2012, In : The Lancet. 379, 9827, p. 1712-1720

    Research output: Contribution to journalArticle

  14. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment

    Kaisa Happonen, Tore Saxne, Pierre Geborek, Maria Andersson, Anders Bengtsson, Roger Hesselstrand, Dick Heinegård & Anna Blom, 2012, In : Arthritis Research and Therapy. 14, 1, R15.

    Research output: Contribution to journalArticle

  15. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial

    Hamed Rezaei, Saedis Saevarsdottir, Kristina Forslind, Kristina Albertsson, Helena Wallin, Johan Bratt, Sofi Ernestam, Pierre Geborek, Ingemar Petersson & Ronald F. van Vollenhoven, 2012, In : Annals of the Rheumatic Diseases. 71, 2, p. 186-191

    Research output: Contribution to journalArticle

  16. Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis.

    Mohamed AbdGawad, Åsa Pettersson, Lena Gunnarsson, Anders Bengtsson, Pierre Geborek, Lars Nilsson, Mårten Segelmark & Thomas Hellmark, 2012, In : PLoS ONE. 7, 3, e32439.

    Research output: Contribution to journalArticle

  17. A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons.

    Pierre Geborek, Elisabeth Nilsson, F Bolzoni & E Jankowska, 2012, In : European Journal of Neuroscience.

    Research output: Contribution to journalArticle

  18. Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

    M. Neovius, J. F. Simard, A. Sundstrom, L Jacobsson, Pierre Geborek, Tore Saxne, N. Feltelius, L. Klareskog & J. Askling, 2011, In : Annals of the Rheumatic Diseases. 70, 3, p. 516-519

    Research output: Contribution to journalArticle

  19. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    S. van Assen, N. Agmon-Levin, O. Elkayam, R. Cervera, M. F. Doran, M. Dougados, P. Emery, Pierre Geborek, J. P. A. Ioannidis, D. R. W. Jayne, C. G. M. Kallenberg, U. Mueller-Ladner, Y. Shoenfeld, L. Stojanovich, G. Valesini, N. M. Wulffraat & M. Bijl, 2011, In : Annals of the Rheumatic Diseases. 70, 3, p. 414-422

    Research output: Contribution to journalArticle

  20. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

    Saedis Saevarsdottir, Helena Wallin, Maria Seddighzadeh, Sofi A. Ernestam, Pierre Geborek, Ingemar Petersson, Johan Bratt & Ronald F. van Vollenhoven, 2011, In : Annals of the Rheumatic Diseases. 70, 3, p. 469-475

    Research output: Contribution to journalArticle

  21. Prevalence of spondyloarthritis and its subtypes in southern Sweden

    Emma Haglund, Ann Bremander, Ingemar Petersson, Britta Strömbeck, Stefan Bergman, Lennart Jacobsson, Aleksandra Turkiewicz, Pierre Geborek & Martin Englund, 2011, In : Annals of the Rheumatic Diseases. 70, p. 943-948

    Research output: Contribution to journalArticle

Previous 1 2 3 Next